Rep. Val T. Hoyle Purchases Shares of McKesson Corporation (NYSE:MCK)

Key Points

• Representative Val T. Hoyle of Oregon purchased between $1,001 and $15,000 in shares of McKesson Corporation (NYSE:MCK) on September 10th, as disclosed in a filing on October 10th.
• McKesson recently reported quarterly earnings of $8.26 per share, missing estimates slightly but achieving a revenue of $97.83 billion, up 23.4% year-over-year.
• The company has increased its quarterly dividend to $0.82 per share, up from $0.71, representing a 0.4% dividend yield.

Representative Val T. Hoyle (D-Oregon) recently bought shares of McKesson Corporation NYSE: MCK. In a filing disclosed on October 10th, the Representative disclosed that they had bought between $1,001 and $15,000 in McKesson stock on September 10th. The trade occurred in the Representative's "FIDELITY ROLLOVER IRA" account.

Representative Val T. Hoyle also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Marriott International NASDAQ: MAR on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Transdigm Group NYSE: TDG on 9/23/2025.
• Sold $1,001 - $15,000 in shares of H&R Block NYSE: HRB on 9/23/2025.
• Sold $1,001 - $15,000 in shares of NIKE NYSE: NKE on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Bank of New York Mellon NYSE: BK on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Cisco Systems NASDAQ: CSCO on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Capital One Financial NYSE: COF on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Pentair NYSE: PNR on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Heico NYSE: HEI.A on 9/23/2025.
• Sold $1,001 - $15,000 in shares of Target NYSE: TGT on 9/23/2025.

McKesson Stock Performance

Shares of NYSE:MCK traded up $5.93 during midday trading on Friday, hitting $763.89. 556,685 shares of the stock were exchanged, compared to its average volume of 782,781. McKesson Corporation has a 52-week low of $492.39 and a 52-week high of $776.14. The business's fifty day simple moving average is $707.48 and its two-hundred day simple moving average is $706.09. The company has a market capitalization of $95.01 billion, a PE ratio of 30.46, a P/E/G ratio of 1.37 and a beta of 0.52.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $8.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.33 by ($0.07). McKesson had a negative return on equity of 196.66% and a net margin of 0.84%.The firm had revenue of $97.83 billion for the quarter, compared to analysts' expectations of $95.93 billion. During the same quarter in the prior year, the business posted $7.88 earnings per share. McKesson's revenue was up 23.4% on a year-over-year basis. As a group, equities analysts anticipate that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 1st. Investors of record on Tuesday, September 2nd were issued a dividend of $0.82 per share. This is a positive change from McKesson's previous quarterly dividend of $0.71. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. The ex-dividend date was Tuesday, September 2nd. McKesson's dividend payout ratio is 13.08%.

Insider Buying and Selling

In other news, CEO Brian S. Tyler sold 11,930 shares of McKesson stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $705.63, for a total value of $8,418,165.90. Following the completion of the transaction, the chief executive officer owned 4,012 shares in the company, valued at approximately $2,830,987.56. The trade was a 74.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the business's stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $663.67, for a total transaction of $218,347.43. Following the completion of the transaction, the chief accounting officer owned 657 shares of the company's stock, valued at $436,031.19. This trade represents a 33.37% decrease in their position. The disclosure for this sale can be found here. Insiders sold 24,189 shares of company stock valued at $16,722,190 in the last quarter. 0.08% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On McKesson

A number of institutional investors have recently added to or reduced their stakes in the company. Marion Wealth Management grew its position in McKesson by 5.5% during the third quarter. Marion Wealth Management now owns 3,071 shares of the company's stock worth $2,372,000 after buying an additional 161 shares in the last quarter. CHICAGO TRUST Co NA raised its stake in shares of McKesson by 3.9% in the third quarter. CHICAGO TRUST Co NA now owns 7,506 shares of the company's stock valued at $5,799,000 after acquiring an additional 284 shares during the last quarter. Abound Wealth Management raised its stake in shares of McKesson by 104.3% in the third quarter. Abound Wealth Management now owns 47 shares of the company's stock valued at $37,000 after acquiring an additional 24 shares during the last quarter. Focus Financial Network Inc. raised its stake in shares of McKesson by 29.1% in the third quarter. Focus Financial Network Inc. now owns 426 shares of the company's stock valued at $330,000 after acquiring an additional 96 shares during the last quarter. Finally, Secure Asset Management LLC bought a new position in shares of McKesson in the third quarter valued at approximately $207,000. 85.07% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on MCK shares. UBS Group raised their target price on McKesson from $820.00 to $860.00 and gave the company a "buy" rating in a report on Wednesday, September 24th. Mizuho raised their target price on McKesson from $750.00 to $770.00 and gave the company a "neutral" rating in a report on Wednesday, September 24th. Wells Fargo & Company raised their target price on McKesson from $772.00 to $816.00 and gave the company an "equal weight" rating in a report on Wednesday, September 24th. Wall Street Zen upgraded McKesson from a "hold" rating to a "buy" rating in a report on Sunday, September 28th. Finally, Cowen reiterated a "buy" rating on shares of McKesson in a research note on Wednesday, September 24th. One analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, McKesson presently has an average rating of "Moderate Buy" and a consensus price target of $829.08.

About Representative Hoyle

Val Hoyle (Democratic Party) is a member of the U.S. House, representing Oregon's 4th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. Hoyle (Democratic Party) is running for re-election to the U.S. House to represent Oregon's 4th Congressional District. She declared candidacy for the 2026 election. Val Hoyle was born in California and lives in Springfield, Oregon. Hoyle graduated from Merrimack High School. She earned a B.A. in political science from Emmanuel College in 1992. Her career experience includes working as a director at United Way of Lane County, a policy fellow at Wayne Morse Center for Law and Politics, and a commissioner at the Oregon Bureau of Labor and Industries. Hoyle has also worked in domestic and international sales, as well as manufacturing distribution.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.